Exane Derivatives’s Target TGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-81
| Closed | -$17.2K | – | 926 |
|
|
2022
Q1 | $17.2K | Buy |
+81
| New | +$17.5K | ﹤0.01% | 668 |
|
|
2021
Q4 | – | Sell |
-1,737
| Closed | -$397K | – | 975 |
|
|
2021
Q3 | $397K | Buy |
1,737
+26
| +2% | +$6.51K | 0.1% | 227 |
|
|
2021
Q2 | $431K | Buy |
1,711
+1,635
| +2,151% | +$358K | 0.1% | 216 |
|
|
2021
Q1 | $15.1K | Sell |
76
-161
| -68% | -$30.1K | ﹤0.01% | 583 |
|
|
2020
Q4 | $41.8K | Sell |
237
-3,583
| -94% | -$598K | 0.01% | 471 |
|
|
2020
Q3 | $601K | Buy |
3,820
+3,313
| +653% | +$455K | 0.17% | 116 |
|
|
2020
Q2 | $60.8K | Sell |
507
-431
| -46% | -$49.2K | 0.02% | 341 |
|
|
2020
Q1 | $87.2K | Sell |
938
-580
| -38% | -$64.4K | 0.02% | 296 |
|
|
2019
Q4 | $178K | Sell |
1,518
-282
| -16% | -$33.1K | 0.03% | 268 |
|
|
2019
Q3 | $192K | Sell |
1,800
-47,574
| -96% | -$4.53M | 0.03% | 260 |
|
|
2019
Q2 | $4.28M | Sell |
49,374
-1,104
| -2% | -$89.2K | 0.75% | 27 |
|
|
2019
Q1 | $4.05M | Sell |
50,478
-2,685
| -5% | -$196K | 0.8% | 31 |
|
|
2018
Q4 | $3.51M | Buy |
53,163
+17,109
| +47% | +$1.32M | 0.63% | 37 |
|
|
2018
Q3 | $3.18M | Buy |
36,054
+34,814
| +2,808% | +$2.9M | 0.6% | 43 |
|
|
2018
Q2 | $95.1K | Sell |
1,240
-30,471
| -96% | -$2.24M | 0.02% | 340 |
|
|
2018
Q1 | $2.19M | Buy |
31,711
+18,046
| +132% | +$1.31M | 0.44% | 52 |
|
|
2017
Q4 | $891K | Buy |
13,665
+9,962
| +269% | +$601K | 0.15% | 107 |
|
|
2017
Q3 | $218K | Sell |
3,703
-1,956
| -35% | -$110K | 0.04% | 195 |
|
|
2017
Q2 | $296K | Buy |
5,659
+292
| +5% | +$16K | 0.06% | 175 |
|
|
2017
Q1 | $296K | Buy |
+5,367
| New | +$334K | 0.07% | 164 |
|
|
2016
Q4 | – | Sell |
-6,514
| Closed | -$447K | – | 679 |
|
|
2016
Q3 | $447K | Sell |
6,514
-740
| -10% | -$53K | 0.07% | 160 |
|
|
2016
Q2 | $506K | Sell |
7,254
-166,742
| -96% | -$12.4M | 0.08% | 130 |
|
|
2016
Q1 | $14.3M | Buy |
+173,996
| New | +$13.1M | 1.9% | 17 |
|
|
2015
Q4 | – | Sell |
-243,418
| Closed | -$19.1M | – | 560 |
|
|
2015
Q3 | $19.1M | Sell |
243,418
-50,613
| -17% | -$4.04M | 2.42% | 4 |
|
|
2015
Q2 | $24M | Buy |
294,031
+286,697
| +3,909% | +$23.2M | 2.58% | 4 |
|
|
2015
Q1 | $602K | Sell |
7,334
-1,257
| -15% | -$97.1K | 0.07% | 127 |
|
|
2014
Q4 | $652K | Buy |
+8,591
| New | +$580K | 0.09% | 124 |
|
Other funds holding TGT
Exane Derivatives's TGT Position: Q2 2022 in Review
Exane Derivatives sold out of Target (TGT) in Q2 2022, closing a stake of 81 shares — an estimated $17.2K sold.
Exane Derivatives first reported a position in TGT in Q4 2014 and held it in 27 quarters. The position peaked at $24M in Q2 2015. 1,931 funds tracked by Wall St. Rank hold TGT as of Q2 2022.
- Exane Derivatives reported no remaining Target position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 81 Target shares in Q2 2022, an estimated $17.2K.
- Exane Derivatives first reported a position in Target in Q4 2014 and held it in 27 quarters.
- Exane Derivatives's Target position peaked at $24M in Q2 2015.
- 1,931 funds tracked by Wall St. Rank held Target as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.